99 related articles for article (PubMed ID: 37391717)
1. The decreased of peripheral blood natural killer cell is associated with serum IL-2 level in the renal tubular acidosis in patients with primary sjogren's syndrome.
Cheng L; Liu L; Su R; Yan H; Zi X; Gao C; Li X; Wang C
BMC Immunol; 2023 Jun; 24(1):17. PubMed ID: 37391717
[TBL] [Abstract][Full Text] [Related]
2. The proportion of CD161 on CD56
Zhao P; Yang Y; Song S; Cheng W; Peng C; Chang X; Wu J; Liu C
Immun Inflamm Dis; 2024 Apr; 12(4):e1244. PubMed ID: 38577997
[TBL] [Abstract][Full Text] [Related]
3. Hypocitraturia as a biomarker of renal tubular acidosis in patients with Sjögren's disease.
Coradin R; Lopes MLL; Goldani JC; Ventura PE; Keitel E
Adv Rheumatol; 2024 Jun; 64(1):45. PubMed ID: 38831360
[TBL] [Abstract][Full Text] [Related]
4. Hypokalemic paralysis as a presenting manifestation of primary Sjögren's syndrome: A report of two cases.
Khandelwal D; Bhattacharya S; Khadgawat R; Kaur S; Tandon N; Ammini AC
Indian J Endocrinol Metab; 2012 Sep; 16(5):853-5. PubMed ID: 23087883
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjögren's syndrome.
Zhao P; Peng C; Chang X; Cheng W; Yang Y; Shen Y; Sun C; Feng X; Liu C; Wu J
Clin Rheumatol; 2024 Jan; 43(1):297-306. PubMed ID: 37749409
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and risk factors of primary Sjögren's syndrome complicated with severe pneumonia: a case-control study.
Cai B; Guo Z; Yan Q; Li H; Song H; Gong Y; Long X
Clin Rheumatol; 2024 May; 43(5):1665-1674. PubMed ID: 38512512
[TBL] [Abstract][Full Text] [Related]
7. Risk factors of primary Sjögren
Huang W; Tian J; He J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 49(2):312-318. PubMed ID: 38755728
[TBL] [Abstract][Full Text] [Related]
8. Distal Renal Tubular Acidosis in Sjögren's Syndrome: A Case Report.
Louis-Jean S; Ching PR; Wallingford A
Cureus; 2020 Oct; 12(10):e10962. PubMed ID: 33083163
[TBL] [Abstract][Full Text] [Related]
9. Related factors of renal injury in primary Sjögren's syndrome.
Duan N; Li Z; Fan Y; Jiang Y; Li H
Immun Ageing; 2023 Sep; 20(1):48. PubMed ID: 37735697
[TBL] [Abstract][Full Text] [Related]
10. A Conundrum of Severe Hypokalaemic Quadriparesis, Acute Kidney Injury, and Lung Involvement as the Initial Presentation of Catastrophic Primary Sjögren's Syndrome: Is it a New Entity? A Case Report.
Mangal V; Vohra G; Adhikari S; Vasudeva A
Mediterr J Rheumatol; 2023 Dec; 34(4):555-559. PubMed ID: 38282934
[TBL] [Abstract][Full Text] [Related]
11. A Case Report of Paralysis and Respiratory Difficulty in a Patient With a Recent History of Complicated Pregnancy - An Uncommon Expression of Distal Renal Tubular Acidosis.
Kumari P; Jitidhar F; Kiran F; Kumar A; Kumar D
Cureus; 2023 Dec; 15(12):e50630. PubMed ID: 38226082
[TBL] [Abstract][Full Text] [Related]
12. Investigative biological therapies for primary Sjögren's syndrome.
He SH; Xuan YY; Liang X; Guo KJ; Wang Y; Fu XN; Li TF
Arch Med Sci; 2024; 20(2):506-516. PubMed ID: 38757038
[TBL] [Abstract][Full Text] [Related]
13. Emerging biologic frontiers for Sjogren's syndrome: Unveiling novel approaches with emphasis on extra glandular pathology.
Li XX; Maitiyaer M; Tan Q; Huang WH; Liu Y; Liu ZP; Wen YQ; Zheng Y; Chen X; Chen RL; Tao Y; Yu SL
Front Pharmacol; 2024; 15():1377055. PubMed ID: 38828450
[TBL] [Abstract][Full Text] [Related]
14. High-content multimodal analysis supports the IL-7/IL-7 receptor axis as a relevant therapeutic target in primary Sjögren's syndrome.
Desvaux E; Hemon P; Soret P; Le Dantec C; Chatzis L; Cornec D; Devauchelle-Pensec V; ; Elouej S; Duguet F; Laigle L; Poirier N; Moingeon P; Bretin S; Pers JO
J Autoimmun; 2023 Dec; ():103147. PubMed ID: 38114349
[TBL] [Abstract][Full Text] [Related]
15. Association between atherosclerosis and primary Sjogren's syndrome: A cross-sectional study.
Liu S; Li X; Yang Q; Wang N; Xu J; Li L; Guo Y
Health Sci Rep; 2023 Oct; 6(10):e1638. PubMed ID: 37885467
[TBL] [Abstract][Full Text] [Related]
16. The Role of Regulatory T Cells in the Onset and Progression of Primary Sjögren's Syndrome.
Blinova VG; Vasilyev VI; Rodionova EB; Zhdanov DD
Cells; 2023 May; 12(10):. PubMed ID: 37408193
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and risk factors of progressive pulmonary fibrosis in primary Sjögren's syndrome-associated interstitial lung disease.
Chen YH; Lee TJ; Hsieh HJ; Hsieh SC; Wang HC; Chang YC; Yu CJ; Chien JY
BMC Pulm Med; 2023 Jul; 23(1):268. PubMed ID: 37468847
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Lushi Runzao decoction on ameliorating Sjogren's syndrome: a network pharmacology and experimental verification-based study.
Fengtao P; Kesong LI; Yi Z; Xiaopo T; Xinyao Z
J Tradit Chin Med; 2023 Aug; 43(4):751-759. PubMed ID: 37454260
[TBL] [Abstract][Full Text] [Related]
19. Involvement of Substance P (SP) and Its Related NK1 Receptor in Primary Sjögren's Syndrome (pSS) Pathogenesis.
Rosso P; Fico E; Colafrancesco S; Bellizzi MG; Priori R; Cerbelli B; Leopizzi M; Giordano C; Greco A; Tirassa P; Severini C; Fusconi M
Cells; 2023 May; 12(10):. PubMed ID: 37408182
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for cardiovascular disease in primary Sjögren's syndrome (pSS): a 20-year follow-up study.
Santos CS; Salgueiro RR; Morales CM; Castro CÁ; Álvarez ED
Clin Rheumatol; 2023 Nov; 42(11):3021-3031. PubMed ID: 37402929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
